Immunology and Vaccine Development in Cancer

• W. Michelle Leeuwon, PhD (Moderator) Cancer Prevention and Research Institute of Texas
• Charles Drake, MD, PhD Janssen Pharmaceuticals Companies of Johnson & Johnson
• COL George Peoples, MD, FACS LumaBridge, LLC
• Robert Yamulla, PhD, MBA Illumina

October 2, 2023
from 2:15 PM - 3:05 PM

Floral Hall B

Panelists will discuss fundamental scientific issues underlying the development and manufacturing of biotherapeutics and vaccines. Experts will address the regulatory, large pharma, and clinical research perspectives during the discussion.